|Bid||282.72 x 100|
|Ask||282.86 x 100|
|Day's Range||281.79 - 284.98|
|52 Week Range||244.28 - 329.83|
|PE Ratio (TTM)||17.66|
|Earnings Date||Oct 24, 2017 - Oct 30, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||327.55|
Biogen is taking a political risk with aggressive multiple sclerosis drug pricing, but the company is under pressure to boost its share price.
NEW YORK, NY / ACCESSWIRE / August 17, 2017 / Biogen saw its market cap increase over $1 billion in Wednesday trading after Goldman Sachs took a big bet on the company by adding it to its "conviction ...